Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Off-clamp and on-clamp robotic-assisted partial nephrectomy in ischemia-sensitive patients: a multicenter propensity score-matched study (RAPN OFF-CLAMP study - UroCCR 187).

Minerva urology and nephrology·2026
Same author

Quantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric Approach.

European journal of neurology·2026
Same author

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Partial Nephrectomy Versus Thermal Ablation for Cystic Renal Tumors: A Registry-Based, Propensity Score Matched Analysis (UroCCR n°177).

Cardiovascular and interventional radiology·2026
Same author

Restoring the interplay between the endoplasmic reticulum and mitochondria by gene therapy improves Charcot-Marie-Tooth type 2A disease.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Accuracy and homogeneity of dictionary-based T2-mapping dedicated to single slice and multi-slice multi-echo turbo-spin echo imaging.

Magnetic resonance imaging·2026

Related Experiment Video

Updated: Jun 28, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.3K

One-Year Longitudinal Assessment of Patients With CMT1A Using Quantitative MRI.

Etienne Fortanier1, Marc Adrien Hostin1, Constance Michel1

  • 1From the Reference Center for Neuromuscular Diseases and ALS (E.F., E.D., S.A.), La Timone University Hospital, Center for Magnetic Resonance in Biology and Medicine (M.A.H., C.M., M.G., D.B.), UMR CNRS 7339, UMR 7286 (E.D.), Medicine Faculty, CNRS, LIS (M.A.H.,M.-E.B.), and Inserm (S.A.), GMGF, Aix-Marseille University, France.

Neurology
|April 17, 2024
PubMed
Summary

Quantitative MRI (qMRI) shows increasing intramuscular fat fraction (FF) in Charcot-Marie-Tooth type 1A (CMT1A) patients over time. This FF metric strongly correlates with disease severity, supporting its use in clinical trials.

More Related Videos

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.5K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.3K

Related Experiment Videos

Last Updated: Jun 28, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.3K
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.5K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

19.3K

Area of Science:

  • Biomedical Imaging
  • Neurology
  • Quantitative MRI

Background:

  • Charcot-Marie-Tooth type 1A (CMT1A) is a progressive peripheral neuropathy.
  • Intramuscular fat fraction (FF) measured by quantitative MRI (qMRI) is a sensitive outcome measure for CMT1A.
  • Longitudinal tracking of qMRI biomarkers is crucial for clinical trial development in CMT1A.

Purpose of the Study:

  • To evaluate the relevance of multiple qMRI biomarkers for tracking longitudinal changes in CMT1A.
  • To assess correlations between qMRI metrics and clinical parameters in CMT1A patients.

Main Methods:

  • Quantitative MRI (qMRI) was performed on CMT1A patients at two time points, one year apart.
  • Metrics including proton density (PD), magnetization transfer ratio (MTR), and intramuscular fat fraction (FF) were extracted from 3D volumes of interest in the thigh and leg.
  • Disease severity was assessed using the Charcot Marie Tooth Neurologic Score (CMTNSv2), Overall Neuropathy Limitation Scale, and Medical Research Council (MRC) muscle strength.

Main Results:

  • Intramuscular fat fraction (FF) significantly increased in both thigh (+1.04%) and leg (+1.36%) 3D volumes over one year.
  • A length-dependent gradient of FF was observed, with higher values in the leg compared to the thigh.
  • Significant correlations were found between FF and clinical measures: CMTNSv2 (ρ = 0.656) and lower limb MRC strength (ρ = -0.877).

Conclusions:

  • Quantitative MRI (qMRI), particularly intramuscular fat fraction (FF), is a promising biomarker for monitoring longitudinal disease progression in CMT1A.
  • Three-dimensional volume analysis is more suitable than single-slice analysis due to varied FF distribution and muscle-specific changes.
  • The minimal annual changes observed necessitate careful data extraction methods for reliable clinical trial application.